Morehouse School of Medicine Selects Head for Institute of Genomic Medicine
Morehouse School of Medicine recently announced that Melissa Boneta Davis was selected
as the first
Georgia Research Alliance (GRA) Distinguished Investigator.
Dr. Melissa Boneta Davis
Georgia Research Alliance (GRA) Distinguished Investigator
By Hannah E. Jones, Saporta Report
Morehouse School of Medicine recently announced that Melissa Boneta Davis was selected as the first Georgia Research Alliance (GRA) Distinguished Investigator. In this role, Davis will spearhead the Institute of Genomic Medicine.
GRA Distinguished Investigators are recruited to the state’s research universities to advance exploration in various fields with the Atlanta-based nonprofit coordinating research efforts between Georgia’s public and private sectors.
Most recently, Davis served several roles with New York’s Weill Cornell Medicine, including:
- Scientific Director of the International Center for the Study of Breast Cancer Subtypes
- Director of Health Equity for the Englander Institute of Precision Medicine
- Associate Professor of Cell and Developmental Biology in the Department of Surgery
“I believe that the importance of diversity in genomics research cannot be overstated, and I will work tirelessly to enhance the capacity of MSM to participate in these transformative investigations,” Davis wrote in a press release. “Minoritized populations have historically been underrepresented in the generation, analysis and application of genomic data and this has perpetuated health disparities. My goal is to ensure that MSM is at the leading edge of the technology and leadership of overcoming this bias and improving the limitations of precision medicine for underserved populations.”